VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 1,600 | -50.2% | 0.00% | -100.0% |
Q2 2022 | $20,000 | -13.0% | 3,210 | -80.8% | 0.00% | +100.0% |
Q1 2022 | $23,000 | -91.9% | 16,700 | -67.2% | 0.00% | -91.7% |
Q4 2021 | $284,000 | -40.1% | 50,937 | +367.4% | 0.01% | -42.9% |
Q3 2021 | $474,000 | +5166.7% | 10,898 | +354.5% | 0.02% | – |
Q2 2021 | $9,000 | -81.6% | 2,398 | -73.1% | 0.00% | -100.0% |
Q1 2021 | $49,000 | +113.0% | 8,900 | -5.4% | 0.00% | +100.0% |
Q4 2020 | $23,000 | -83.5% | 9,406 | +12.2% | 0.00% | -87.5% |
Q3 2020 | $139,000 | +239.0% | 8,386 | +59.1% | 0.01% | +300.0% |
Q2 2020 | $41,000 | +272.7% | 5,270 | +229.4% | 0.00% | +100.0% |
Q1 2020 | $11,000 | – | 1,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |